Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage
Background Myocardial fibrosis (MF) in noninfarcted myocardium may be an interstitial disease pathway that confers vulnerability to hospitalization for heart failure, death, or both across the spectrum of heart failure and ejection fraction. Hospitalization for heart failure is an epidemic that is d...
Main Authors: | Erik B. Schelbert, Kayla M. Piehler, Karolina M. Zareba, James C. Moon, Martin Ugander, Daniel R. Messroghli, Uma S. Valeti, Chung‐Chou H. Chang, Sanjeev G. Shroff, Javier Diez, Christopher A. Miller, Matthias Schmitt, Peter Kellman, Javed Butler, Mihai Gheorghiade, Timothy C. Wong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-12-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://doi.org/10.1161/JAHA.115.002613 |
Similar Items
-
Role of the cardiac extracellular matrix in the onset and progression of heart failure
by: N. N. Ilov, et al.
Published: (2021-07-01) -
How does the Extracellular Matrix Change in the Setting of Heart Failure?
by: Amerikos Argyriou
Published: (2018-12-01) -
Application of Bioengineered Materials in the Surgical Management of Heart Failure
by: Simranjit S. Pattar, et al.
Published: (2019-08-01) -
Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics
by: Abdulla Ahmed, et al.
Published: (2020-02-01) -
CARDIOPROTECTIVE PROPERTIES OF PROGESTINES: INFLUENCE OF DROSPIRENONE ON MYOCARD IN EXPERIMENTAL HEART FAILURE
by: Yu. V. Liskova, et al.
Published: (2017-07-01)